Prime Therapeutics Rolls Out New Real Time Benefit Tool

With the deadline approaching for Medicare Part D plans to implement a Real Time Benefit Tool (RTBT) — which informs prescribers when lower-cost alternative therapies are available under a beneficiary’s drug benefit — one PBM is offering up a new tool to fulfill the requirement.

Prime Therapeutics, LLC, a PBM collectively owned by 18 Blue Cross and Blue Shield plans, said on Sept. 2 that it is rolling out a tool called Real Time Benefit Check, which works through the ePrescribe function of a health care provider’s electronic health record (EHR) system. The idea is to offer providers “comprehensive information so they can easily prescribe the most appropriate and cost-effective medications at the point of care,” per a news release from the PBM.

© 2022 MMIT
Leslie Small

Leslie Small

Leslie has been reporting and editing in various journalism roles for nearly a decade. Most recently, she was the senior editor of FierceHealthPayer, an e-newsletter covering the health insurance industry. A graduate of Penn State University, she previously served in editing roles at newspapers in Pennsylvania, Virginia and Colorado.

Related Posts

pills
September 22

Report Shows Limited Access to Opioid Use Disorder Treatments for Medicare Beneficiaries

READ MORE
cms-website
September 22

Drug Price Negotiation Will Require New CMS Regulations, Staffing

READ MORE
fda-sign
September 22

Accelerated Approval Prices Are Unrelated to Clinical Value, Study Says

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today